Merck schizophrenia drug approved for 2 new uses

Pin It

Merck & Co. said Tuesday its schizophrenia drug Saphris has been approved for two additional uses by the Food and Drug Administration.

The drug was first approved in August 2009 for treating acute schizophrenia episodes in adults and acute mania or manic-depressive behavior in adults with bipolar disorder.

Merck says the FDA now has approved Saphris for ongoing treatment of schizophrenia and for treating acute mania or manic-depressive behavior in adult bipolar patients along with lithium, a mood-stabilizing drug often used to treat mania, or the antiseizure drug valproate.

Reported by LINDA A. JOHNSON
Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2010/09/07/AR2010090703772.html

Submitted by Anna

Speak Your Mind

*